We are live on ! Find out more
ABBV icon

AbbVie

1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0%68.14% (+68%)

33% more call options, than puts

Call options by funds: $182M | Put options by funds: $137M

Holders
1,286
Holders Change
+1,286
Holders Change %
% of All Funds
41.97%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,286
Increased
Reduced
Closed
Calls
$182M
Puts
$137M
Net Calls
+$45.2M
Net Calls Change
+$45.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ABBV Hedge Fund Activity: Q2 2013 in Review

1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.

Based on aggregated 13F filings for Q2 2013.